Long-term follow-up in AIDS clinical trials

Statistics in Medicine

Volumn 15, Issue 21-22, 1996, Pages 2359-2366

  Schoenfeld, David A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; HUMAN; PATIENT MONITORING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CLINICAL TRIALS; DATA COLLECTION; FOLLOW-UP STUDIES; HUMANS; MODELS, THEORETICAL; MONTE CARLO METHOD; SURVIVAL ANALYSIS;

EID: 0029908034     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19961115)15:21<2359::AID-SIM454>3.0.CO;2-W     Document Type: Conference Paper

References (2)

1. Byar, D. P., Schoenfeld, D. A., Green, S. B., Amato, D. A., Anderson, J. R., Collins, R., Davis, R., De Gruttola, V., Ellenberg, S. S., Finkelstein, D. M., Freedman, L. S., Gail, M., Gatsonis, C., Gelber, R. D., Lagakos, S., Lefkopoulou, M., Peto, J., Peto, R., Peto, T., Simon, R., Tsiatis A. A. and Zelen, M. 'Design Considerations for AIDS trials', New England Journal of Medicine, 323, 1343-1348 (1990).
2. Epstein, A. E., Hallstrom, A. P., Rogers, W. J., Liebson, P. R., Seals, A. A., Anderson, J. L., Cohen, J. D., Capone, R. J. and Wyse, D. G. 'Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST)', Journal of the American Medical Association, 270, (20), 2451-2455 (1993).